• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Hydrogels

8 drug delivery innovations you need to know

February 25, 2021 By Sean Whooley

Drug Delivery Innovations you need to know

The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9

Filed Under: Auto-injectors, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Hydrogels, Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Research & Development, Respiratory, Technology Tagged With: dyvebioscience, Enable Injections, evoxtherapeutics, Inovio Pharmaceuticals, Johns Hopkins, Lyra Therapeutics, Medtronic, Tandem Diabetes Care, Teva, Teva Pharmaceuticals, Teva Respiratory

Axonics acquires Contura and its Bulkamid bulking agent for $235M

February 25, 2021 By Sean Whooley

Axonics (NSDQ: AXNX) announced today that it acquired Contura and its flagship Bulkamid product for up to $235 million. London-based Contura’s Bulkamid is a urethral bulking agent for women with stress urinary incontinence (SUI). It is a next-generation hydrogel injected into the urethral wall in a minimally invasive office or outpatient facility procedure to restore the natural closing pressure […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Hydrogels, Mergers & Acquisitions, Pharmaceuticals, Women's Health Tagged With: Axonics Modulation Technologies, Contura

AmacaThera raises $10.3M in oversubscribed Series A

February 22, 2021 By Sean Whooley

AmacaThera announced today that it completed an oversubscribed $10.3 million Series A financing round. Lumira Ventures led the Series A funding, with existing investors Viva BioInnovator and Sprout BioVentures contributing as well. New investors BDC Capital Women in Technology Venture Fund, Inveready, MBX Capital, CR Capital Management, StandUp Ventures and MaRS IAF participated, too, according […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Hydrogels, Pain Management, Pharmaceuticals, Surgical Tagged With: AmacaThera

Contura wins FDA premarket approval for hydrogel injection

February 4, 2020 By Sean Whooley

Contura announced that it won FDA premarket approval for its Bulkamid hydrogel injection for treating stress urinary incontinence (SUI). Bulkamid is Contura’s proprietary device designed for treating SUI due to intrinsic sphincter deficiency in adult women with SUI or stress predominant mixed incontinence. According to a news release, the product is currently marketed in more […]

Filed Under: Featured, Hydrogels, Women's Health Tagged With: Contura

Frequency Therapeutics launches hearing loss trial, gains the fast track at FDA

October 10, 2019 By Brad Perriello

Frequency Therapeutics updated logo

Frequency Therapeutics (NSDQ:FREQ) said today that it launched a Phase 2a study and won fast-track designation at the FDA for its regenerative hearing loss drug. The fast-track program aims to speed up the approval of therapies for unmet needs in serious conditions. Woburn, Mass.-based Frequency’s FX-322 candidate is designed to stimulate the regrowth of sensory hair cells […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Hydrogels, Regulatory/Compliance Tagged With: Frequency Therapeutics

Frequency Therapeutics registers $100m IPO

September 9, 2019 By Sean Whooley

Frequency Therapeutics updated logo

Frequency Therapeutics has registered an initial public offering of common stock worth $100 million. Woburn, Mass.-based Frequency Therapeutics did not disclose the number of shares it seeks to sell or the price range of the offered units. The company applied to the Securities and Exchange Commission have its common stock listed on The Nasdaq Global […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Hydrogels, Initial Public Offering (IPO), Otolaryngology Ear, Nose & Throat, Research & Development, Stem Cells Tagged With: Frequency Therapeutics

Veramorph lands spot in Delaware accelerator

July 30, 2019 By Brad Perriello

Veramorph Materials

Veramorph Materials landed a spot in a Delaware business accelerator backed by DuPont to develop its hydrogel-based oral drug delivery platform. Veramorph and MCET Technologies (which is developing wearable sensor technology) won their spots in the Delaware Innovation Space via the DuPont FastPass competition. The companies get a year of free access to the accelerator, […]

Filed Under: Featured, Funding Roundup, Hydrogels Tagged With: Veramorph Materials

Ocular Therapeutix doses first wet-AMD patient in implant trial

February 20, 2019 By Sarah Faulkner

Ocular Therapeutix logo

Ocular Therapeutix (NSDQ:OCUL) said today that it dosed the first patient in a study of its OTX-TKI tyrosine kinase inhibitor implant. The Phase I trial is slated to assess the bioresorbable device’s safety, durability and tolerability in people with wet age-related macular degeneration. The company’s investigational product is a bioresorbable hydrogel fiber implant formulated with a […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Hydrogels, Implants, Optical/Ophthalmic, Pharmaceuticals, Wall Street Beat Tagged With: Ocular Therapeutix

How suppliers are taking drug-delivery tech to the next level

September 14, 2018 By Heather Thompson

ProMed Pharma medtech suppliers drug delivery tech

Medical device industry suppliers and outsourcers are helping to enable the latest drug-delivery tech. Drug-eluting technologies are moving beyond stents, thanks in part to the development of polymeric hydrogels engineered to respond to a range of different physical and chemical stimuli. Medtech innovators have figured out how to use hydrogels as components of micro-shells or […]

Filed Under: Contract Services, Discovery, Drug-Device Combinations, Featured, Hydrogels, Nanoparticles, Stents Tagged With: Freudenberg Sealing Technologies, freudenbergmedical, freudenbergmedicalhemoteq, lubrizol, promedpharma, Trelleborg, Trelleborg Sealing Solutions

Gelesis touts study of hydrogel obesity drug

September 25, 2017 By Sarah Faulkner

Gelesis

PureTech subsidiary Gelesis today touted results from a pivotal weight-loss study of its obesity drug, Gelesis100. The study met one of its two primary endpoints, with 58% of adults in the treatment arm experiencing clinically-meaningful weight loss of 5% or more. Nearly twice as many adults lost 10% or more of the body weight in the […]

Filed Under: Clinical Trials, Featured, Hydrogels, Pharmaceuticals Tagged With: gelesis

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS